Senores Pharmaceuticals Share Price Target : Are you thinking of investing in Senores Pharmaceuticals shares? Want to know its future price target? In this guide, we will discuss Senores Pharmaceuticals share price target for the year 2024, 2025, 2026, 2030. Along with this, we will do a complete fundamental analysis to help you make the right decision.
We are a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets across various therapeutic areas and dosage forms, with a presence in Emerging Markets.
Our strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing us as a preferred partner to certain customers.
Through data analytics, research, market assessment and experienced management, we strategically identify commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets. We leverage our R&D capabilities to develop and manufacture a portfolio of differentiated complex pharmaceutical products.
Our focus on quality and our ability to identify specialty and complex molecules has resulted in an extensive pipeline of curated complex products spanning diverse dosage forms and therapeutic domains, demonstrated through our partnerships in the Regulated Markets with prominent foreign and Indian pharmaceutical companies including Prasco LLC, Lannett Company Inc., Jubilant Cadista Pharmaceuticals Inc., Alkem Laboratories Limited, Sun Pharmaceuticals Industries Limited, Dr. Reddy’s Laboratories Inc. and Cipla USA Inc.
Our business is primarily focussed on the Regulated Markets of US and Canada. We have a presence in the Emerging Markets across 43 countries. We also manufacture critical care injectables and APIs.
| Fundamentals | Senores Pharmaceuticals |
|---|---|
| Market Cap | ₹2,639 Cr |
| 52 Week High | 609.00 |
| 52 Week Low | 538.35 |
| NSE Symbol | SENORES |
| ROE | 15.40% |
| P/E Ratio | 83.89 |
| EPS | 6.83 |
| P/B Ratio | 3.43 |
| Dividend Yield | 0.00% |
| Industry P/E | 38.27 |
| Book Value | 166.96 |
| Debt to Equity | 1.26 |
| Stock Face Value | 10 |
Senores Pharmaceuticals Shareholding Pattern
| Promoters | 45.76% |
|---|---|
| Retail & Others | 33.75% |
| DII | 9.35% |
| FII | 5.51% |
| Mutual Funds | 5.62% |
The Senores Pharmaceuticals Financial Reports
| Sector | Year (2024) |
|---|---|
| Revenue | 215 Cr. |
| Expense | 173 Cr. |
| Profit Before Tax | 25 Cr. |
| Net Profit | 23 Cr. |
Senores Pharmaceuticals Share Price Target 2025
The share price of Senores Pharmaceuticals may Ups & Down. According to our analysis levels, the minimum price of Senores Pharmaceuticals share in 2025 can be ₹530 and the maximum price can be ₹640.
| Month Wise (Year 2025) | Target Price |
|---|---|
| January | ₹530 |
| February | ₹537 |
| March | ₹532 |
| April | ₹545 |
| May | ₹556 |
| June | ₹565 |
| July | ₹578 |
| August | ₹589 |
| September | ₹608 |
| October | ₹620 |
| November | ₹633 |
| December | ₹640 |
Also Read: JBM Auto Share Price Target 2024, 2025, 2026, 2030 to 2050
Senores Pharmaceuticals Share Price Target 2026
The share price of Senores Pharmaceuticals may Ups & Down. According to our analysis levels, the minimum price of Senores Pharmaceuticals share in 2026 can be ₹631 and the maximum price can be ₹780.
| Month Wise (Year 2026) | Target Price |
|---|---|
| January | ₹631 |
| December | ₹780 |
Also Read: HDFC Life Share Price Target 2024, 2025, 2026, 2030 to 2050
Senores Pharmaceuticals Share Price Target 2030
The share price of Senores Pharmaceuticals may Ups & Down. According to our analysis levels, the minimum price of Senores Pharmaceuticals share in 2030 can be ₹1,150 and the maximum price can be ₹1,326.
| Month Wise (Year 2030) | Target Price |
|---|---|
| January | ₹1150 |
| December | ₹1326 |
Also Read: Shree Renuka Sugar Share Price Target 2024, 2025, 2030 to 2050
Senores Pharmaceuticals Share Price Target 2040
The share price of Senores Pharmaceuticals may Ups & Down. According to our analysis levels, the minimum price of Senores Pharmaceuticals share in 2040 can be ₹2,250 and the maximum price can be ₹3,000.
| Month Wise (Year 2040) | Target Price |
|---|---|
| January | ₹2250 |
| December | ₹3000 |
Also Read: Vodafone Idea Share Price Target 2024, 2025, 2026, 2030 to 2050
Senores Pharmaceuticals Share Price Target 2050
The share price of Senores Pharmaceuticals may Ups & Down. According to our analysis levels, the minimum price of Senores Pharmaceuticals share in 2050 can be ₹4,900 and the maximum price can be ₹6,000.
| Month Wise (Year 2050) | Target Price |
|---|---|
| January | ₹4900 |
| December | ₹6000 |
Also Read: Tata Steel Share Price Target 2024, 2025, 2026, 2030 to 2050
Senores Pharmaceuticals Financial Information
Competative Strengths
- Ability to cater to the Regulated Markets through our US FDA approved formulation manufacturing facility in the US.
- Distinct niche product portfolio built in a short span for Regulated Markets.
- Long-term marketing arrangements with pharmaceutical companies in the Regulated Markets.
- Presence in the Emerging Markets with a strong product portfolio, including specialty or complex products.
- Strong R&D capabilities driving our differentiated portfolio of products.
- Professional and dedicated management teams for our diverse business verticals.
How To Buy Senores Pharmaceuticals Share?
To buy Senores Pharmaceuticals shares, you can easily buy shares of Senores Pharmaceuticals by using the trading platform of many stock brokers.
The names of most trading platforms for buying Senores Pharmaceuticals shares are given below.
- Groww App
- Phonepe. Share Market App
- Angel One App
- Dhan App
- Upstox App
- Zerodha App
Disclaimer :- The above article is for informational purposes only, and should not be construed as any investment advice. Money Mint idea suggests its readers/viewers to consult their financial advisors before making any money-related decisions.
